ClinicalTrials.gg
RecruitingNCT07414680Updated Jul 30, 2026

Integrating Systematic Data of Medicine to Explore the Solution for Healthy Aging (ISDHA) Phase 4

An observational study in Sleep Disturbance, Cognitive Change and Aging, sponsored by Chang Gung Memorial Hospital. Recruiting at 2 sites in Taiwan. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Chang Gung Memorial Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
250
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Dementia by Chang Gung Memorial Hospital — 9 open to participants now, 10 under way, none of them phase 3. Dementia · Chang Gung Memorial Hospital.

Started
2026
with 4 others
Observational
2 of 23
1 open now
Registered
20th of 23
by date

Among the 23 studies in Dementia by Chang Gung Memorial Hospital, this one is one of 5 that started in 2026, is one of 2 observational ones, and was the 20th registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

9 of the 23 studies in Dementia by Chang Gung Memorial Hospital are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 40 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Dementia by Chang Gung Memorial Hospital, or all of them as a file.
02

Study summary

This project aims to build up the comprehensive health database of geriatric medicine for middle-aged and elderly people in Taiwan.

Read the detailed description

This project aims to establish a comprehensive local health database for adults aged 40 and above by integrating clinical data, functional assessments, genomics, metabolomics, and gut microbiome profiles.

The project focuses on validating metabolomic and genetic biomarkers associated with sarcopenia and developing predictive models for early risk identification. Longitudinal multi-omics analyses will be conducted using blood, urine, and fecal samples to explore metabolic dynamics and their links to aging-related conditions. In parallel, the study examines brain health and psychosocial factors, including sleep, resilience, apathy, and loneliness, to better understand their roles in cognitive function and healthy aging.

Through the integration of large-scale health data and advanced analytical approaches, this project aims to support early detection, personalized intervention strategies, and the development of precision healthy aging models.

03

Conditions studied

  • Sleep Disturbance
  • Cognitive Change
  • Aging

Keywords

  • dementia
  • depression
  • brain structure
  • system biology
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

By collecting data from participants in the "Integrating Systemic Geriatric Medical Information to Explore Solutions for Healthy Aging (Pilot Project)," the "Integrating Systemic Geriatric Medical Information to Explore Solutions for Healthy Aging" main project, and the "Integrating Systemic Medical Information to Explore Solutions for Healthy Aging" project, approximately 100 individuals aged 60 and above, residing in Songshan District of Taipei City, Chang Gung Health and Wellness Village, and Senior Citizens' Health Activity Centers (Shuanglian, New Taipei City; Delai, Taoyuan City), were included. Additionally, 100-150 middle-aged employees aged 40-59 from Chang Gung Hospital, Formosa Plastics Group, and Chang Gung University were also included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willing to sign a written participant consent form.
  • Males or females aged 40 or above who have participated in the "Integrated Systematic Geriatric Medical Information to Explore Solutions for Healthy Aging (Pilot Project)," the "Integrated Systematic Geriatric Medical Information to Explore Solutions for Healthy Aging" master planner, or the "Integrated Systematic Medical Information to Explore Solutions for Healthy Aging" project (not subject to exclusion criteria).
  • Males or females aged 40-59 who have participated in health checkups for employees of Chang Gung Memorial Hospital, Formosa Plastics Group, or Chang Gung University.
  • Those with a medical record of more than one year at Chang Gung Memorial Hospital.
  • Those who have resided in Taiwan for more than 180 days in the past year.

Exclusion criteria

Exclusion Criteria:

  • Individuals with severe organ abnormalities, such as: heart failure ( Fc ≥ III), (hospitalization/emergency room visit or medication adjustment within the past month due to disease worsening), decompensated cirrhosis, hemodialysis, or currently undergoing cancer treatment.
  • Individuals with a history of severe diseases.
  • Individuals with a preliminary cognitive and mental assessment score of \<26 on the (MMSE) or ≥5 on the Generalized Depression Scale (GDS).
  • Individuals (who agree to undergo brain MRI) who are deemed unsuitable for MRI after evaluation (e.g., those with pacemakers, cochlear implants, or spatial phobia).
  • Individuals who have taken antibiotics within the past month.
  • Individuals whose hearing, vision, or cognitive impairments affect communication.
  • Individuals unable to stand or walk (with a walking aid) or with unsteady gait when walking.
  • Those who have undergone follow-up outpatient assessments that may affect cognitive function, including but not limited to stroke, Parkinson's syndrome, Parkinson's dementia, epilepsy, brain tumor, or a history of mental illness such as schizophrenia, severe depression, bipolar disorder, alcohol or drug abuse, or a history of loss of consciousness due to severe head trauma.
  • Those currently diagnosed with depression and undergoing treatment.
  • Those with a past medical history confirming dementia, depression, etc..
  • Those deemed unsuitable by a physician.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
250 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. The brain volume of local Taiwanese aged over 40 years old

    Measure the volume of cerebrum, cerebellum, and skin of skull (unit in mm3) by magnetic resonance imaging

    Time frame: one hour

Secondary outcomes

  1. The actigraphy of local Taiwanese aged over 40 years old

    Measure the circadian rhythm (unit in minute) by Actiwatch

    Time frame: two weeks

  2. The sleep quality questionnaire of local Taiwanese aged over 40 years old

    Measure the sleep quality (unit in score) by Pittsburgh Sleep Quality Index (PSQI, Score range: 0 \~ 21, higher is worse)

    Time frame: one day

  3. The gut microbiota of local Taiwanese aged over 40 years old

    Fecal samples were analyzed using 16s full length rRNA gene sequencing to characterize the composition and diversity of the gut microbiota

    Time frame: one day

  4. The metabolism of local Taiwanese aged over 40 years old

    Nuclear Magnetic Resonance (NMR) spectroscopy was employed to perform metabolic profiling of blood samples, with metabolite concentrations quantified in mg/dL, respectively

    Time frame: one day

  5. The metabolism of local Taiwanese aged over 40 years old

    Nuclear Magnetic Resonance (NMR) spectroscopy was employed to perform metabolic profiling of urine samples, with metabolite concentrations quantified in mM, respectively

    Time frame: one day

  6. The sleep quality questionnaire of local Taiwanese aged over 40 years old

    Measure the sleep quality (unit in score) by Stop-Bang Questionnaire (Score range: 0 \~ 8, higher is worse)

    Time frame: one day

  7. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Mini-Mental State Examination Score (MMSE, Score range: 0 \~ 30, higher is better)

    Time frame: one day

  8. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Geriatric Depression Scale (GDS, Score range: 0 \~ 15, higher is worse)

    Time frame: one day

  9. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Short Physical Performance Battery Score (SPPB, Score range: 0 \~ 12, higher is better)

    Time frame: one day

  10. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Clinical Frailty Scale (CFS, Score range: 1 \~ 9, higher is worse)

    Time frame: one day

  11. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Apathy Evaluation Scale (AES, Score range: 18 \~ 72, higher is worse)

    Time frame: one day

  12. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Connor-Davidson Resilience Scale (CD-RISC2, Score range: 0 \~ 8, higher is better)

    Time frame: one day

  13. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by UCLA Loneliness Scale (UCLA, Score range: 20 \~ 80, higher is worse)

    Time frame: one day

  14. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Consortium to Establish a Registry for Alzheimer's Disease - Neuropsychological Assessment Battery (CERAD-NAB, Score range: 0 \~ 100, higher is better)

    Time frame: one day

  15. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Hamilton Anxiety Rating Scale (HAM-A, Score range: 0 \~ 56, higher is worse)

    Time frame: one day

  16. The mental/neurocognitive condition questionnaire of local Taiwanese aged over 40 years old

    Measure the mental/neurocognitive condition (unit in score) by Hamilton Depression Rating Scale (HAM-D, Score range: 0 \~ 56, higher is worse)

    Time frame: one day

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Dec 2028, 27 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2026
First posted
Feb 17, 2026
StartEst.
Sep 15, 2026
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Jul 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07414680
Collaborators
Chang Gung University
Responsible party
JI-TSENG FANG (Professor, Chang Gung Memorial Hospital) — Principal investigator
First posted
Feb 17, 2026
Start date
Sep 15, 2026 (estimated)
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jul 30, 2026

Study contacts

JI-TSENG FANG, Professor
Contact
fangjits@cgmh.org.tw
+886-3-3281200

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion